Good morning, everyone, and nice to see you again. We hope the weekend respite was refreshing and relaxing, because that oh-so-familiar routine of meetings, deadlines, conference calls, and the like has, predictably, returned. But what can you do? The world, after all, keeps spinning. So to cope, we are firing up the coffee kettle to brew a few cups of stimulation. Our flavor today is caramel cream, for those tracking this sort of thing. Meanwhile, here are a few tidbits to get you started. Hope your journey goes well today and you conquer the world. …

Attorneys general from more than 40 states are alleging the nation’s largest generic drug makers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis, and other medical conditions, the Associated Press writes. The lawsuit, filed in federal court in Connecticut on Friday, also names 15 individual senior executives responsible for sales, marketing, and pricing along with 20 different companies. The suit was the second that has been filed in the price-fixing investigation. Here is the first one.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy